Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Pulmonary arterial hypertension.

McLaughlin VV, McGoon MD.

Circulation. 2006 Sep 26;114(13):1417-31. Review. No abstract available.

2.

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

Williams MH, Das C, Handler CE, Akram MR, Davar J, Denton CP, Smith CJ, Black CM, Coghlan JG.

Heart. 2006 Jul;92(7):926-32. Epub 2005 Dec 9.

3.

Autoantibodies in systemic sclerosis.

Steen VD.

Semin Arthritis Rheum. 2005 Aug;35(1):35-42.

PMID:
16084222
4.

Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach.

Robertson L, Pignone A, Kowal-Bielecka O, Fiori G, Denton CP, Matucci-Cerinic M.

Ann Rheum Dis. 2005 Jun;64(6):804-7. No abstract available.

5.

Mortality in systemic sclerosis: an international meta-analysis of individual patient data.

Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den Hoogen F, Te Boome L, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM.

Am J Med. 2005 Jan;118(1):2-10.

PMID:
15639201
6.

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F, Giuggioli D, Cuomo G, Rosada M, Bombardieri S, Todesco S, Tirri G; Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc).

Medicine (Baltimore). 2002 Mar;81(2):139-53. Review. No abstract available.

7.

Severe organ involvement in systemic sclerosis with diffuse scleroderma.

Steen VD, Medsger TA Jr.

Arthritis Rheum. 2000 Nov;43(11):2437-44.

8.

Long-term outcomes of scleroderma renal crisis.

Steen VD, Medsger TA Jr.

Ann Intern Med. 2000 Oct 17;133(8):600-3.

PMID:
11033587
9.
10.

Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.

Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM.

Arthritis Rheum. 1999 Mar;42(3):465-74.

11.

South Australian Scleroderma Register: analysis of deceased patients.

Bond C, Pile KD, McNeil JD, Ahern MJ, Smith MD, Cleland LG, Roberts-Thomson PJ.

Pathology. 1998 Nov;30(4):386-90.

PMID:
9839314
12.

Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)

Jacobsen S, Halberg P, Ullman S.

Br J Rheumatol. 1998 Jul;37(7):750-5.

PMID:
9714351
13.

Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis).

Bulpitt KJ, Clements PJ, Lachenbruch PA, Paulus HE, Peter JB, Agopian MS, Singer JZ, Steen VD, Clegg DO, Ziminski CM, Alarcon GS, Luggen ME, Polisson RP, Willkens RF, Reading JC, Williams HJ, Ward JR.

Ann Intern Med. 1993 Apr 15;118(8):602-9.

PMID:
8452326
14.

Autoantibody reactive with RNA polymerase III in systemic sclerosis.

Okano Y, Steen VD, Medsger TA Jr.

Ann Intern Med. 1993 Nov 15;119(10):1005-13.

PMID:
8214977
15.

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.

Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H.

Ann Intern Med. 1971 Sep;75(3):369-76. No abstract available.

PMID:
4105464
16.

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.

Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr.

Ann Intern Med. 1990 Sep 1;113(5):352-7.

PMID:
2382917
17.

Predictors of survival in systemic sclerosis (scleroderma).

Altman RD, Medsger TA Jr, Bloch DA, Michel BA.

Arthritis Rheum. 1991 Apr;34(4):403-13.

PMID:
1901491

Supplemental Content

Support Center